Copyright Reports & Markets. All rights reserved.

Global Neurorehabilitation Devices Supply, Demand and Key Producers, 2026-2032

Buy now

1 Supply Summary

  • 1.1 Neurorehabilitation Devices Introduction
  • 1.2 World Neurorehabilitation Devices Market Size & Forecast (2021 & 2025 & 2032)
  • 1.3 World Neurorehabilitation Devices Total Market by Region (by Headquarter Location)
    • 1.3.1 World Neurorehabilitation Devices Market Size by Region (2021-2032), (by Headquarter Location)
    • 1.3.2 United States Based Company Neurorehabilitation Devices Revenue (2021-2032)
    • 1.3.3 China Based Company Neurorehabilitation Devices Revenue (2021-2032)
    • 1.3.4 Europe Based Company Neurorehabilitation Devices Revenue (2021-2032)
    • 1.3.5 Japan Based Company Neurorehabilitation Devices Revenue (2021-2032)
    • 1.3.6 South Korea Based Company Neurorehabilitation Devices Revenue (2021-2032)
    • 1.3.7 ASEAN Based Company Neurorehabilitation Devices Revenue (2021-2032)
    • 1.3.8 India Based Company Neurorehabilitation Devices Revenue (2021-2032)
  • 1.4 Market Drivers, Restraints and Trends
    • 1.4.1 Neurorehabilitation Devices Market Drivers
    • 1.4.2 Factors Affecting Demand
    • 1.4.3 Major Market Trends

2 Demand Summary

  • 2.1 World Neurorehabilitation Devices Consumption Value (2021-2032)
  • 2.2 World Neurorehabilitation Devices Consumption Value by Region
    • 2.2.1 World Neurorehabilitation Devices Consumption Value by Region (2021-2026)
    • 2.2.2 World Neurorehabilitation Devices Consumption Value Forecast by Region (2027-2032)
  • 2.3 United States Neurorehabilitation Devices Consumption Value (2021-2032)
  • 2.4 China Neurorehabilitation Devices Consumption Value (2021-2032)
  • 2.5 Europe Neurorehabilitation Devices Consumption Value (2021-2032)
  • 2.6 Japan Neurorehabilitation Devices Consumption Value (2021-2032)
  • 2.7 South Korea Neurorehabilitation Devices Consumption Value (2021-2032)
  • 2.8 ASEAN Neurorehabilitation Devices Consumption Value (2021-2032)
  • 2.9 India Neurorehabilitation Devices Consumption Value (2021-2032)

3 World Neurorehabilitation Devices Companies Competitive Analysis

  • 3.1 World Neurorehabilitation Devices Revenue by Player (2021-2026)
  • 3.2 Industry Rank and Concentration Rate (CR)
    • 3.2.1 Global Neurorehabilitation Devices Industry Rank of Major Players
    • 3.2.2 Global Concentration Ratios (CR4) for Neurorehabilitation Devices in 2025
    • 3.2.3 Global Concentration Ratios (CR8) for Neurorehabilitation Devices in 2025
  • 3.3 Neurorehabilitation Devices Company Evaluation Quadrant
  • 3.4 Neurorehabilitation Devices Market: Overall Company Footprint Analysis
    • 3.4.1 Neurorehabilitation Devices Market: Region Footprint
    • 3.4.2 Neurorehabilitation Devices Market: Company Product Type Footprint
    • 3.4.3 Neurorehabilitation Devices Market: Company Product Application Footprint
  • 3.5 Competitive Environment
    • 3.5.1 Historical Structure of the Industry
    • 3.5.2 Barriers of Market Entry
    • 3.5.3 Factors of Competition
  • 3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)

  • 4.1 United States VS China: Neurorehabilitation Devices Revenue Comparison (by Headquarter Location)
    • 4.1.1 United States VS China: Neurorehabilitation Devices Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
    • 4.1.2 United States VS China: Neurorehabilitation Devices Revenue Market Share Comparison (2021 & 2025 & 2032)
  • 4.2 United States Based Companies VS China Based Companies: Neurorehabilitation Devices Consumption Value Comparison
    • 4.2.1 United States VS China: Neurorehabilitation Devices Consumption Value Comparison (2021 & 2025 & 2032)
    • 4.2.2 United States VS China: Neurorehabilitation Devices Consumption Value Market Share Comparison (2021 & 2025 & 2032)
  • 4.3 United States Based Neurorehabilitation Devices Companies and Market Share, 2021-2026
    • 4.3.1 United States Based Neurorehabilitation Devices Companies, Headquarters (States, Country)
    • 4.3.2 United States Based Companies Neurorehabilitation Devices Revenue, (2021-2026)
  • 4.4 China Based Companies Neurorehabilitation Devices Revenue and Market Share, 2021-2026
    • 4.4.1 China Based Neurorehabilitation Devices Companies, Company Headquarters (Province, Country)
    • 4.4.2 China Based Companies Neurorehabilitation Devices Revenue, (2021-2026)
  • 4.5 Rest of World Based Neurorehabilitation Devices Companies and Market Share, 2021-2026
    • 4.5.1 Rest of World Based Neurorehabilitation Devices Companies, Headquarters (Province, Country)
    • 4.5.2 Rest of World Based Companies Neurorehabilitation Devices Revenue (2021-2026)

5 Market Analysis by Type

  • 5.1 World Neurorehabilitation Devices Market Size Overview by Type: 2021 VS 2025 VS 2032
  • 5.2 Segment Introduction by Type
    • 5.2.1 Implantable Neurorehabilitation System
    • 5.2.2 Neurorobotic System
    • 5.2.3 Brain Computer Interface
    • 5.2.4 Non-invasive Stimulators
    • 5.2.5 Other
  • 5.3 Market Segment by Type
    • 5.3.1 World Neurorehabilitation Devices Market Size by Type (2021-2026)
    • 5.3.2 World Neurorehabilitation Devices Market Size by Type (2027-2032)
    • 5.3.3 World Neurorehabilitation Devices Market Size Market Share by Type (2027-2032)

6 Market Analysis by Application

  • 6.1 World Neurorehabilitation Devices Market Size Overview by Application: 2021 VS 2025 VS 2032
  • 6.2 Segment Introduction by Application
    • 6.2.1 Hospitals
    • 6.2.2 Clinics
    • 6.2.3 Other
  • 6.3 Market Segment by Application
    • 6.3.1 World Neurorehabilitation Devices Market Size by Application (2021-2026)
    • 6.3.2 World Neurorehabilitation Devices Market Size by Application (2027-2032)
    • 6.3.3 World Neurorehabilitation Devices Market Size Market Share by Application (2021-2032)

7 Company Profiles

  • 7.1 Medtronic
    • 7.1.1 Medtronic Details
    • 7.1.2 Medtronic Major Business
    • 7.1.3 Medtronic Neurorehabilitation Devices Product and Services
    • 7.1.4 Medtronic Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.1.5 Medtronic Recent Developments/Updates
    • 7.1.6 Medtronic Competitive Strengths & Weaknesses
  • 7.2 Abbott Laboratories
    • 7.2.1 Abbott Laboratories Details
    • 7.2.2 Abbott Laboratories Major Business
    • 7.2.3 Abbott Laboratories Neurorehabilitation Devices Product and Services
    • 7.2.4 Abbott Laboratories Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.2.5 Abbott Laboratories Recent Developments/Updates
    • 7.2.6 Abbott Laboratories Competitive Strengths & Weaknesses
  • 7.3 Boston Scientific
    • 7.3.1 Boston Scientific Details
    • 7.3.2 Boston Scientific Major Business
    • 7.3.3 Boston Scientific Neurorehabilitation Devices Product and Services
    • 7.3.4 Boston Scientific Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.3.5 Boston Scientific Recent Developments/Updates
    • 7.3.6 Boston Scientific Competitive Strengths & Weaknesses
  • 7.4 Bioness
    • 7.4.1 Bioness Details
    • 7.4.2 Bioness Major Business
    • 7.4.3 Bioness Neurorehabilitation Devices Product and Services
    • 7.4.4 Bioness Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.4.5 Bioness Recent Developments/Updates
    • 7.4.6 Bioness Competitive Strengths & Weaknesses
  • 7.5 Hocoma AG
    • 7.5.1 Hocoma AG Details
    • 7.5.2 Hocoma AG Major Business
    • 7.5.3 Hocoma AG Neurorehabilitation Devices Product and Services
    • 7.5.4 Hocoma AG Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.5.5 Hocoma AG Recent Developments/Updates
    • 7.5.6 Hocoma AG Competitive Strengths & Weaknesses
  • 7.6 Neuronetics
    • 7.6.1 Neuronetics Details
    • 7.6.2 Neuronetics Major Business
    • 7.6.3 Neuronetics Neurorehabilitation Devices Product and Services
    • 7.6.4 Neuronetics Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.6.5 Neuronetics Recent Developments/Updates
    • 7.6.6 Neuronetics Competitive Strengths & Weaknesses
  • 7.7 Yiruide
    • 7.7.1 Yiruide Details
    • 7.7.2 Yiruide Major Business
    • 7.7.3 Yiruide Neurorehabilitation Devices Product and Services
    • 7.7.4 Yiruide Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.7.5 Yiruide Recent Developments/Updates
    • 7.7.6 Yiruide Competitive Strengths & Weaknesses
  • 7.8 Magstim
    • 7.8.1 Magstim Details
    • 7.8.2 Magstim Major Business
    • 7.8.3 Magstim Neurorehabilitation Devices Product and Services
    • 7.8.4 Magstim Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.8.5 Magstim Recent Developments/Updates
    • 7.8.6 Magstim Competitive Strengths & Weaknesses
  • 7.9 VISHEE
    • 7.9.1 VISHEE Details
    • 7.9.2 VISHEE Major Business
    • 7.9.3 VISHEE Neurorehabilitation Devices Product and Services
    • 7.9.4 VISHEE Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.9.5 VISHEE Recent Developments/Updates
    • 7.9.6 VISHEE Competitive Strengths & Weaknesses
  • 7.10 Ekso Bionics
    • 7.10.1 Ekso Bionics Details
    • 7.10.2 Ekso Bionics Major Business
    • 7.10.3 Ekso Bionics Neurorehabilitation Devices Product and Services
    • 7.10.4 Ekso Bionics Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.10.5 Ekso Bionics Recent Developments/Updates
    • 7.10.6 Ekso Bionics Competitive Strengths & Weaknesses
  • 7.11 Alter G
    • 7.11.1 Alter G Details
    • 7.11.2 Alter G Major Business
    • 7.11.3 Alter G Neurorehabilitation Devices Product and Services
    • 7.11.4 Alter G Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.11.5 Alter G Recent Developments/Updates
    • 7.11.6 Alter G Competitive Strengths & Weaknesses
  • 7.12 MagVenture
    • 7.12.1 MagVenture Details
    • 7.12.2 MagVenture Major Business
    • 7.12.3 MagVenture Neurorehabilitation Devices Product and Services
    • 7.12.4 MagVenture Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.12.5 MagVenture Recent Developments/Updates
    • 7.12.6 MagVenture Competitive Strengths & Weaknesses
  • 7.13 Tyromotion
    • 7.13.1 Tyromotion Details
    • 7.13.2 Tyromotion Major Business
    • 7.13.3 Tyromotion Neurorehabilitation Devices Product and Services
    • 7.13.4 Tyromotion Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.13.5 Tyromotion Recent Developments/Updates
    • 7.13.6 Tyromotion Competitive Strengths & Weaknesses
  • 7.14 Soterix Medical
    • 7.14.1 Soterix Medical Details
    • 7.14.2 Soterix Medical Major Business
    • 7.14.3 Soterix Medical Neurorehabilitation Devices Product and Services
    • 7.14.4 Soterix Medical Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.14.5 Soterix Medical Recent Developments/Updates
    • 7.14.6 Soterix Medical Competitive Strengths & Weaknesses
  • 7.15 Neuroelectrics
    • 7.15.1 Neuroelectrics Details
    • 7.15.2 Neuroelectrics Major Business
    • 7.15.3 Neuroelectrics Neurorehabilitation Devices Product and Services
    • 7.15.4 Neuroelectrics Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.15.5 Neuroelectrics Recent Developments/Updates
    • 7.15.6 Neuroelectrics Competitive Strengths & Weaknesses
  • 7.16 Bionik Laboratories
    • 7.16.1 Bionik Laboratories Details
    • 7.16.2 Bionik Laboratories Major Business
    • 7.16.3 Bionik Laboratories Neurorehabilitation Devices Product and Services
    • 7.16.4 Bionik Laboratories Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.16.5 Bionik Laboratories Recent Developments/Updates
    • 7.16.6 Bionik Laboratories Competitive Strengths & Weaknesses
  • 7.17 Helius Medical
    • 7.17.1 Helius Medical Details
    • 7.17.2 Helius Medical Major Business
    • 7.17.3 Helius Medical Neurorehabilitation Devices Product and Services
    • 7.17.4 Helius Medical Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2021-2026)
    • 7.17.5 Helius Medical Recent Developments/Updates
    • 7.17.6 Helius Medical Competitive Strengths & Weaknesses

8 Industry Chain Analysis

  • 8.1 Neurorehabilitation Devices Industry Chain
  • 8.2 Neurorehabilitation Devices Upstream Analysis
  • 8.3 Neurorehabilitation Devices Midstream Analysis
  • 8.4 Neurorehabilitation Devices Downstream Analysis

9 Research Findings and Conclusion

    10 Appendix

    • 10.1 Methodology
    • 10.2 Research Process and Data Source

    The global Neurorehabilitation Devices market size is expected to reach $ 4317 million by 2032, rising at a market growth of 12.2% CAGR during the forecast period (2026-2032).
    Neurorehabilitation devices helps to improve function, reduce symptoms and improve the wellbeing of people with diseases such as trauma or disorders of the nervous system. Infections, tumours, disorders, degenerative diseases, injuries and structural defects in the circulatory system can impair the nervous system.
    North America is the largest consumption place for Neurorehabilitation devices, with a consumption market share over 40%, followed by Europe. Medtronic, Abbott, Boston Scientific, Bioness and Hocoma AG are the major manufacturers in this industry, with Medtronic having the largest market share, exceeding 30%. The classification of Neurorehabilitation devices includes Implantable Neurorehabilitation System, Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, etc. They have been widely used in hospitals and clinics
    This report studies the global Neurorehabilitation Devices demand, key companies, and key regions.
    This report is a detailed and comprehensive analysis of the world market for Neurorehabilitation Devices, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neurorehabilitation Devices that contribute to its increasing demand across many markets.
    Highlights and key features of the study
    Global Neurorehabilitation Devices total market, 2021-2032, (USD Million)
    Global Neurorehabilitation Devices total market by region & country, CAGR, 2021-2032, (USD Million)
    U.S. VS China: Neurorehabilitation Devices total market, key domestic companies, and share, (USD Million)
    Global Neurorehabilitation Devices revenue by player, revenue and market share 2021-2026, (USD Million)
    Global Neurorehabilitation Devices total market by Type, CAGR, 2021-2032, (USD Million)
    Global Neurorehabilitation Devices total market by Application, CAGR, 2021-2032, (USD Million)
    This report profiles major players in the global Neurorehabilitation Devices market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Abbott Laboratories, Boston Scientific, Bioness, Hocoma AG, Neuronetics, Yiruide, Magstim, VISHEE, Ekso Bionics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Neurorehabilitation Devices market
    Detailed Segmentation:
    Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
    Global Neurorehabilitation Devices Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World
    Global Neurorehabilitation Devices Market, Segmentation by Type:
    Implantable Neurorehabilitation System
    Neurorobotic System
    Brain Computer Interface
    Non-invasive Stimulators
    Other
    Global Neurorehabilitation Devices Market, Segmentation by Application:
    Hospitals
    Clinics
    Other
    Companies Profiled:
    Medtronic
    Abbott Laboratories
    Boston Scientific
    Bioness
    Hocoma AG
    Neuronetics
    Yiruide
    Magstim
    VISHEE
    Ekso Bionics
    Alter G
    MagVenture
    Tyromotion
    Soterix Medical
    Neuroelectrics
    Bionik Laboratories
    Helius Medical
    Key Questions Answered
    1. How big is the global Neurorehabilitation Devices market?
    2. What is the demand of the global Neurorehabilitation Devices market?
    3. What is the year over year growth of the global Neurorehabilitation Devices market?
    4. What is the total value of the global Neurorehabilitation Devices market?
    5. Who are the Major Players in the global Neurorehabilitation Devices market?
    6. What are the growth factors driving the market demand?

    Buy now